期刊文献+

幽门螺杆菌基因hpaA克隆、融合表达和鉴定 被引量:1

Cloning,fusion expression and identification of the adhesion gene hpaA from Helicobacter pylori
下载PDF
导出
摘要 目的克隆幽门螺杆菌粘附素基因hpaA,构建幽门螺杆菌hpaA基因与麦芽糖结合蛋白基因融合表达载体,并进行诱导表达,鉴定融合蛋白免疫原性,为幽门螺杆菌疫苗研究提供依据。方法利用PCR技术从H.pylori郑州分离株MEL-HP27染色体DNA上扩增出hpaA基因,序列分析后,将其克隆到表达载体pMAL-c2X中,转化大肠杆菌(E.coliTB1),用IPTG诱导目的基因表达,SDS-PAGE方法对表达产物进行分析,Western blot鉴定其免疫原性。结果用PCR方法扩增的hpaA基因长度为783bp,编码260个氨基酸,经酶切鉴定和测序,插入到克隆载体的基因片段与预期目的DNA片段相一致;SDS-PAGE结果显示表达产物相对分子质量约为29kDa,融合蛋白的表达量约占全菌总蛋白的26%。结论本研究成功构建了hpaA基因与麦芽糖结合蛋白基因融合原核表达系统,为幽门螺杆菌基因工程组分疫苗的研究奠定基础。 To clone the adhesion gene hpaA of Helicobacter pylori, and to construct the expression vector expressing the fusion of the hpaA gene of Helicobacter pylori and the gene coding maltose binding protein, the hpaA gene of Helicobacter pylori strain MEL-HP27 was amplified by PCR. After being purified, the target fragment was cloned into plasmid pBlueseriptb Ⅱ and subject to nucleotide sequencing. Then,hpaA gene from recombinant plasmid pBluescriptb Ⅱ-hpaA was digested with restriction enzyme and was inserted into expression vector pMAL-c2X. The positive recombinants were transferred into E. coli TB1 and identified by restriction enzyme digestion and PCR. Finally, the genetically engineered bacteria including pMAL- e2X-hpaA plasmids were induced by IPTG, and the expression products were analyzed by SDS-PAGE and Western blotting. Results show that hpaA gene of 783bp, encoding the polypeptides of 260 amino acids, is obtained from the Helicobacter pylori strains MEL-HP27 genome DNA. The gene segment inserted into the recombinant vector was identified by using restriction enzyme digestion and sequencing, Plasmid pMAL-c2X-hpaA could express a specific approximative 72kDa fusion protein(HpaA 29kDa and MBP 42.5kDa) in E, coli TB1, and the fusion protein accounted for 26% of the total protein of recombinant bacterial. In this study, a prokaryotic high expression system for fusion hpaA and maltose gene was successfully constructed, which will help to develop gene recombinant vaccine against Helicobacter pylori infection.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2007年第3期274-277,281,共5页 Chinese Journal of Zoonoses
基金 河南省医学创新人才基金资助项目(No.2000-84)
关键词 幽门螺杆菌 粘附素基因 克隆 融合表达 Helicobacterpylori hpaA genes cloning fusion expression
  • 相关文献

参考文献13

  • 1Ohata H,Kitauchi S,Yoshimura N,et al.Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer[J].Int J Cancer,2004,109 (1):138-143.
  • 2Kauseer F,Hussain MA,Amed I,et al.Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England[J].BMC Microbioc,2005,5(1):32.
  • 3Danesh J.Helicobacter pylori infection and gastric cancer:systematic review of the epidemiological studies[J].Aliment Pharmacol Ther,1999,13(7):851-856.
  • 4Valkonen KH,Wadstrom T,Moran AP.Identification of the Nacetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori[J].Infect Immun,1997,65(3):916-923.
  • 5Simon PM,Goode PL,Mobasseri A,et al.Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acidcontaining oligosaccharides[J].Infect Immun,1997,65(2):750-757.
  • 6Alm RA,Ling LS,Morr DT,et al.Genomic sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori[J].Nature,1999,397(6715):176-180.
  • 7Opazo P,Muller I,Urra S,et al.Serological response to Helicobacter pylori recombinant antigens in Chilean infected patients with duodenal ulcer,non-ulcer dyspepsia and gastric cancer[J].APMIS,1999,107(12):1069-1078.
  • 8张荣光,段广才.幽门螺杆菌lpp20基因的克隆与表达[J].胃肠病学和肝病学杂志,2003,12(2):156-158. 被引量:3
  • 9康巧珍,段广才,范清堂,郗园林.幽门螺杆菌中性白细胞激活蛋白基因napA克隆及序列分析[J].郑州大学学报(医学版),2004,39(5):743-745. 被引量:2
  • 10Koesling J,Lucas B,Develioglou L,et al.Vaccination of mice with live recombinant Salmonella typhimurium aroA against Helicobacter pylori:parameter sassociated with prophylactic and therapeutic vaccine efficacy[J].Vaccine,2001,20 (3-4):413-420.

二级参考文献18

  • 1周永宁,徐采朴.幽门螺杆菌中性白细胞激活蛋白的研究进展[J].免疫学杂志,2001,17(z1):53-55. 被引量:5
  • 2SambrookJ FritschEF ManiatisT著 金冬雁 黎孟枫等译.分子克隆实验指南第2版[M].北京:科学技术出版社,2002.16-69.
  • 3[1]Neilsen H, Andersen LP. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut, 1992,33(6) :738
  • 4[2]Satin B, Del Giudice G, Della Bianca V. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med, 2000,191(9): 1 467
  • 5[3]Del Giudice G, Covacci A, Telford JL, et al. The design of vaccines against Helicobacter pylori and their development.Annu Rev Immunol. 2001,19:523
  • 6[5]Evans DJ Jr, Evans DG, Lanpert HC, et al. Identification of four new prokaryotic bacferioferioferritins, from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequence. Gene,1995, 153(1): 123
  • 7[6]Rokbi B, Seguin D, Guy B, et al. Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR. Infect Immun, 2001, 69(8): 4 759
  • 8[7]Allen LA. Modulating phagocyte activation: the pros and cons of helicobacter pylori virulence factors. Exp Med, 2000,191(9): 1 451
  • 9[8]Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther, 1996,10( Suppl. 1 ) :29
  • 10[9]Neilsen H, Birkholz S, Andersen LP. Neutrophil activation by Helicobacter pylori lipopolysaccharide. Infect Dis, 1994,170(1) :135

共引文献3

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部